# 5. Study Population

The study will enroll a total of 1,170 patients with cancer and symptomatic or incidental acute
proximal deep vein thrombosis (DVT) or pulmonary embolism (PE). The randomised cohort is
planned to include approximately 671 patients.
Prospective approval of protocol deviations to recruitment and enrollment criteria, also known as
protocol waivers or exemptions, will not be permitted.